1. Home
  2. VKTX vs PAGP Comparison

VKTX vs PAGP Comparison

Compare VKTX & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • PAGP
  • Stock Information
  • Founded
  • VKTX 2012
  • PAGP 2013
  • Country
  • VKTX United States
  • PAGP United States
  • Employees
  • VKTX N/A
  • PAGP 4200
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • PAGP Natural Gas Distribution
  • Sector
  • VKTX Health Care
  • PAGP Energy
  • Exchange
  • VKTX Nasdaq
  • PAGP Nasdaq
  • Market Cap
  • VKTX 3.5B
  • PAGP 3.8B
  • IPO Year
  • VKTX 2015
  • PAGP 2013
  • Fundamental
  • Price
  • VKTX $40.03
  • PAGP $18.83
  • Analyst Decision
  • VKTX Strong Buy
  • PAGP Hold
  • Analyst Count
  • VKTX 13
  • PAGP 8
  • Target Price
  • VKTX $86.92
  • PAGP $20.71
  • AVG Volume (30 Days)
  • VKTX 4.6M
  • PAGP 1.5M
  • Earning Date
  • VKTX 07-23-2025
  • PAGP 08-08-2025
  • Dividend Yield
  • VKTX N/A
  • PAGP 8.07%
  • EPS Growth
  • VKTX N/A
  • PAGP N/A
  • EPS
  • VKTX N/A
  • PAGP 0.69
  • Revenue
  • VKTX N/A
  • PAGP $47,796,000,000.00
  • Revenue This Year
  • VKTX N/A
  • PAGP N/A
  • Revenue Next Year
  • VKTX $338.60
  • PAGP $22.50
  • P/E Ratio
  • VKTX N/A
  • PAGP $27.35
  • Revenue Growth
  • VKTX N/A
  • PAGP N/A
  • 52 Week Low
  • VKTX $18.92
  • PAGP $16.61
  • 52 Week High
  • VKTX $81.73
  • PAGP $22.31
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 69.97
  • PAGP 38.31
  • Support Level
  • VKTX $39.35
  • PAGP $18.74
  • Resistance Level
  • VKTX $41.68
  • PAGP $19.63
  • Average True Range (ATR)
  • VKTX 2.06
  • PAGP 0.37
  • MACD
  • VKTX 0.56
  • PAGP -0.08
  • Stochastic Oscillator
  • VKTX 84.10
  • PAGP 7.76

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests

Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.

Share on Social Networks: